רפמיון 1 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

SIROLIMUS 1.00 MG

Mevcut itibaren:

NEOPHARM LTD

ATC kodu:

L04AA10

Farmasötik formu:

COATED TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

PFIZER IRELAND PHARMACEUTICALS

Terapötik grubu:

SIROLIMUS

Terapötik endikasyonlar:

Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Yetkilendirme tarihi:

2009-10-01